|
CYP2C8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.264480E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.186000E-01 |
| Normal-vs-Stage2 |
2.441400E-01 |
| Normal-vs-Stage3 |
3.716800E-01 |
| Normal-vs-Stage4 |
3.660200E-01 |
| Stage1-vs-Stage2 |
3.211600E-01 |
| Stage1-vs-Stage3 |
4.614000E-01 |
| Stage1-vs-Stage4 |
5.229800E-01 |
| Stage2-vs-Stage3 |
9.146800E-01 |
| Stage2-vs-Stage4 |
5.273200E-01 |
| Stage3-vs-Stage4 |
6.630800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.175400E-03 |
| Normal-vs-AfricanAmerican |
8.882800E-01 |
| Normal-vs-Asian |
7.820400E-02 |
| Caucasian-vs-AfricanAmerican |
5.901400E-03 |
| Caucasian-vs-Asian |
1.642410E-04 |
| AfricanAmerican-vs-Asian |
5.046100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.215500E-03 |
| Normal-vs-Female |
5.793200E-01 |
| Male-vs-Female |
6.224800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.412600E-01 |
| Normal-vs-Extreme_Weight |
1.208820E-01 |
| Normal-vs-Obese |
1.138180E-01 |
| Normal-vs-Extreme_Obese |
4.338600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.315800E-01 |
| Normal_Weight-vs-Obese |
5.688400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.061400E-01 |
| Extreme_Weight-vs-Obese |
5.452600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.847200E-01 |
| Obese-vs-Extreme_Obese |
5.709200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.797700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.873800E-02 |
| Normal-vs-Age(61-80Yrs) |
3.545600E-02 |
| Normal-vs-Age(81-100Yrs) |
6.426600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.196300E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.571940E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.297900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.742800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.255580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.602800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.261800E-03 |
| Normal-VS-Type2 PRCC |
3.254200E-01 |
| Normal-VS-KIRP CIMP |
6.81810000013883E-07 |
| Normal-VS-Unclassified PRCC |
2.165200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.838000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.62436730732907E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
7.719800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.250410E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.589000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.434110E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.983700E-02 |
| Normal-vs-N1 |
3.728000E-01 |
| Normal-vs-N2 |
7.143200E-01 |
| N0-vs-N1 |
3.741200E-01 |
| N0-vs-N2 |
8.482000E-01 |
| N1-vs-N2 |
8.466600E-01 |
|
|
